CGC Financial Services’s Pulse Biosciences PLSE Stock Holding History

CGC Financial Services’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.69K	Hold	133	–	–	﹤0.01%	275
2026 Q1	$2.87K	Hold	133	–	–	﹤0.01%	273
2025 Q4	$1.83K	Hold	133	–	–	﹤0.01%	293
2025 Q3	$2.35K	Hold	133	–	–	﹤0.01%	286
2025 Q2	$2.01K	Hold	133	–	–	﹤0.01%	277
2025 Q1	$2.14K	Hold	133	–	–	﹤0.01%	270
2024 Q4	$2.32K	Hold	133	–	–	﹤0.01%	274
2024 Q3	$2.33K	Hold	133	–	–	﹤0.01%	270
2024 Q2	$1.49K	Hold	133	–	–	﹤0.01%	283
2024 Q1	$1.16K	Buy	+133	New	+$1.22K	﹤0.01%	301

Other funds holding PLSE

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

CGC Financial Services's PLSE Position: Q2 2026 in Review

CGC Financial Services held its Pulse Biosciences (PLSE) position steady in Q2 2026 at 133 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #275.

CGC Financial Services first reported a position in PLSE in Q1 2024 and has held it in 10 quarters since. 4 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

CGC Financial Services held 133 shares of Pulse Biosciences worth $3.69K as of Q2 2026.
CGC Financial Services left its Pulse Biosciences share count unchanged in Q2 2026.
Pulse Biosciences made up ﹤0.01% of CGC Financial Services's portfolio in Q2 2026, its #275 holding.
CGC Financial Services first reported a position in Pulse Biosciences in Q1 2024 and has held it in 10 quarters since.
4 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on CGC Financial Services's 13F filing for Q2 2026, filed 13 Jul 2026.